The tips in this section are based on published general guidelines for managing certain side effects that are common among patients with advanced kidney cancer (advanced RCC) or other cancers. You can find a list of possible serious side effects in the Important Safety Information for INLYTA.
Studies show that treatment can have both benefits and risks. Keep in mind that while taking INLYTA with pembrolizumab, side effects are expected. Not all side effects are manageable. Dose interruptions and/or reductions may be needed during treatment with INLYTA, pembrolizumab, or both. Be sure to pay attention to all your side effects. They can be important signs that let you and your healthcare provider know what is happening in your body.
Before starting INLYTA, tell your healthcare provider how you are feeling and about any side effects you have had from other medications and treatments. As you start taking INLYTA, let your healthcare provider know if you notice any side effects or a change in how you feel. Also tell your healthcare provider if you notice any side effects that are not listed below.
If your healthcare provider prescribes INLYTA for you to be taken in combination with pembrolizumab, also read the Medication Guide for pembrolizumab.
INLYTA in combination with pembrolizumab may cause your blood pressure to rise. In a clinical trial of INLYTA alone, hypertension occurred as early as 4 days into treatment. On average, this increase was seen within the first month of treatment.
Follow your healthcare provider’s instructions about having your blood pressure checked regularly. Call your healthcare provider if your blood pressure is too high.
Your healthcare provider may recommend that you:
If you develop blood pressure problems, your healthcare provider may lower your dose, stop your treatment, or prescribe medicine to treat your high blood pressure. Tell your healthcare provider if you have high blood pressure or a history of heart disease.
Diarrhea is defined as 3 or more loose or watery stools/bowel movements in 1 day. If you have these symptoms, call your healthcare provider. It is important for you and your healthcare provider to try to manage diarrhea as soon as it begins.
Diarrhea can be a symptom of a more severe medical condition, so it’s important to call your healthcare provider right away. He or she may give you ways to help manage it and may adjust or stop your treatment if needed.
While on treatment, you may feel tired or weak. Call your healthcare provider if you have these symptoms. Ask your healthcare provider if there are over-the-counter or prescription medicines that may help you manage your condition.
During treatment, you may have less desire to eat. But maintaining good nutrition and a healthy weight are important to your overall health. Protein and calories are especially vital to someone with cancer.
If you vomit, start with small amounts of water, broth, or other clear liquids when you are ready to eat again. If that stays down, then try soft foods. Some examples include gelatin, pudding, yogurt, strained soup, or strained cooked cereal. Slowly work up to eating solid food. Make sure that you do not eat any food that you are allergic to.
Hoarseness is when you have a weak, rough, or harsh voice.
Skin conditions, such as rash, redness, itching, or peeling of the skin are other side effects that may occur. You may notice dryness, thickening, calluses, blisters, or cracking of the skin on the palms of your hands and soles of your feet. This is called hand-foot syndrome.
Some patients taking INLYTA experience constipation during treatment. This has the potential to become a serious side effect. Left untreated, constipation can cause a blockage in your intestines, leading to dehydration and even internal damage.
Let your healthcare provider know right away if you’re experiencing any side effect. He or she may give you ways to help manage it and may adjust or stop your treatment if needed. If side effects become too severe over time, they could cause permanent discontinuation from treatment. Make sure that you talk with your healthcare team about your side effects so that they can help you manage them early on.
View full Prescribing Information
DOWNLOAD GUIDE
Download a guide to help discuss your experience taking INLYTA with pembrolizumab with your healthcare provider.View full Prescribing Information |
|
Before taking INLYTA, tell your healthcare provider about all of your medical conditions, including if you:
For females, tell your healthcare provider if you:
For males with female partners who are able to become pregnant:
INLYTA may cause fertility problems in males and females, which may affect your ability to have a child. Talk to your healthcare provider if this is a concern for you.
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. INLYTA and certain other medicines can affect each other causing serious side effects.
Talk with your healthcare provider before you start taking any new medicine. Know the medicines you take. Keep a list of them to show your healthcare provider and pharmacist when you get a new medicine.
Do not drink grapefruit juice or eat grapefruit. Grapefruit may increase the amount of INLYTA in your blood.
INLYTA may cause serious side effects, including:
The most common side effects of INLYTA with pembrolizumab include:
Important information: If your healthcare provider prescribes INLYTA for you to be taken with pembrolizumab, also read the Medication Guide for pembrolizumab.
The most common side effects of INLYTA when used alone include:
These are not all of the possible side effects of INLYTA. Call your healthcare provider for medical advice about side effects. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Please see full Prescribing Information and Patient Information, which includes a complete discussion of the risks of INLYTA.
INLYTA is a prescription medicine used to treat kidney cancer that has spread or cannot be removed by surgery (advanced renal cell carcinoma or RCC):
It is not known if INLYTA is safe and effective in children.
INLYTA is a prescription medicine used to treat kidney cancer that has spread or cannot be removed by surgery (advanced renal cell carcinoma or RCC):
It is not known if INLYTA is safe and effective in children.
A mass of cancer cells.
A disease of the arteries (commonly called high blood pressure).
Located throughout the body, lymph nodes filter lymph fluid. They store special cells that can trap cancer cells or bacteria that are traveling through the body in the lymph.
One of a pair of organs that removes waste products from the blood. In the process, they make urine to help carry waste products out of the body. One is on the left side of the abdomen. The other is on the right side.
INLYTA (axitinib) is a prescription medicine used to treat kidney cancer that has spread or cannot be removed by surgery (advanced renal cell carcinoma or RCC):
It is not known if INLYTA is safe and effective in children.
Cancer that has spread from one part of the body to another through the lymphatic system or bloodstream.